10.2337/dc24-S002 [DOI] [PMC free article] [PubMed] [Google Scholar] Asghari P., Babaei A., Zamanian N., Eshtivani E
In mammals, LC treatment activated the main marker proteins of mitophagy, such as PINK1, Parkin, BCL2/adenovirus E1B 19 kDa protein interacting protein 3 (BNIP-3) and microtubule-associated protein 1 light chain 3 B-II (LC3B-II) (Reference Sabry, Ahmed and Maksoud73,Reference Choi, Ohn and Jung75) , and decreased hepatic 8-hydroxydeoxyguanosine in rats (Reference Chang, Nishikawa and Nishiguchi79)
Cells 12 (7), 991
This white paper takes a deep dive into the connection between butyrate, a short-chain fatty acid produced in the gut and its role in enhancing glucagon-like peptide-1 (GLP-1) production
At the time of writing, published literature on Body Protection Compound 157 is primarily limited to laboratory and preclinical investigations
Rehydra + Wellness offers membership subscriptions for semaglutide and tirzepatide that help patients receive medication on a recurring schedule, with autopay and automated delivery designed to reduce interruptions and keep treatment moving
:max_bytes(150000):strip_icc()/Health-GettyImages-2153927815-0bf99cd73e2c46908d7fc0973739f6d0.jpg)
